|
5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
1.503e-149 |
1.00
|
5HT3B_RAT |
Htr3b |
5-hydroxytryptamine receptor 3B |
2.982e-70 |
1.00
|
5HT3A_RAT |
Htr3a |
5-hydroxytryptamine receptor 3A |
7.085e-55 |
1.00
|
5HT3B_HUMAN |
HTR3B |
5-hydroxytryptamine receptor 3B |
1.089e-50 |
1.00
|
S22A2_HUMAN |
SLC22A2 |
Solute carrier family 22 member 2 |
3.331e-16 |
1.00
|
S47A1_HUMAN |
SLC47A1 |
Multidrug and toxin extrusion protein 1 |
2.22e-15 |
1.00
|
KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
0.004329 |
1.00
|
5HT4R_HUMAN |
HTR4 |
5-hydroxytryptamine receptor 4 |
1.19e-90 |
0.55
|
5HT4R_MOUSE |
Htr4 |
5-hydroxytryptamine receptor 4 |
1.254e-78 |
0.50
|
OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
2.242e-78 |
0.33
|
BCAT2_HUMAN |
BCAT2 |
Branched-chain-amino-acid aminotransferase, mitochondrial |
1.033e-49 |
0.35
|
GLRA1_RAT |
Glra1 |
Glycine receptor subunit alpha-1 |
2.077e-48 |
0.34
|
ACHA7_MACMU |
CHRNA7 |
Neuronal acetylcholine receptor subunit alpha-7 |
1.921e-39 |
0.31
|
Q8VBU5_MOUSE |
Pde4b |
Phosphodiesterase |
5.403e-33 |
0.32
|
Q54A96_PLAFA |
dhod |
Dihydroorotate dehydrogenase |
6.461e-21 |
0.37
|
SC6A3_BOVIN |
SLC6A3 |
Sodium-dependent dopamine transporter |
1.248e-19 |
0.31
|
CFAD_HUMAN |
CFD |
Complement factor D |
6.736e-19 |
0.36
|
INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
5.011e-18 |
0.32
|
PDE7A_HUMAN |
PDE7A |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
4.441e-16 |
0.32
|
5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
8.882e-16 |
0.50
|
CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
2.887e-15 |
0.39
|
DRD3_RAT |
Drd3 |
D(3) dopamine receptor |
7.216e-15 |
0.42
|
BCAT1_HUMAN |
BCAT1 |
Branched-chain-amino-acid aminotransferase, cytosolic |
8.66e-15 |
0.32
|
CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
1.343e-13 |
0.35
|
OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.786e-13 |
0.41
|
ACM5_RAT |
Chrm5 |
Muscarinic acetylcholine receptor M5 |
1.315e-12 |
0.31
|
OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
2.768e-12 |
0.33
|
5HT4R_CAVPO |
HTR4 |
5-hydroxytryptamine receptor 4 |
7.881e-12 |
0.52
|
SC6A3_RAT |
Slc6a3 |
Sodium-dependent dopamine transporter |
1.19e-11 |
0.37
|
ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
1.802e-11 |
0.37
|
RPA1_HUMAN |
POLR1A |
DNA-directed RNA polymerase I subunit RPA1 |
2.606e-11 |
0.31
|
5HT3A_CAVPO |
HTR3A |
5-hydroxytryptamine receptor 3A |
3.22e-11 |
0.34
|
PER2_HUMAN |
PER2 |
Period circadian protein homolog 2 |
1.039e-10 |
0.31
|
HYEP_MOUSE |
Ephx1 |
Epoxide hydrolase 1 |
2.03e-10 |
0.30
|
CNR2_RAT |
Cnr2 |
Cannabinoid receptor 2 |
4.065e-10 |
0.32
|
DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
1.033e-09 |
0.42
|
CRFR2_HUMAN |
CRHR2 |
Corticotropin-releasing factor receptor 2 |
1.476e-09 |
0.29
|
5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
1.816e-09 |
0.37
|
ACHA7_MOUSE |
Chrna7 |
Neuronal acetylcholine receptor subunit alpha-7 |
5.304e-09 |
0.34
|
CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
6.426e-09 |
0.36
|
CNR2_MOUSE |
Cnr2 |
Cannabinoid receptor 2 |
6.577e-09 |
0.33
|
SMAD3_HUMAN |
SMAD3 |
Mothers against decapentaplegic homolog 3 |
6.935e-09 |
0.35
|
B9W6M3_CANDC |
CNA1 |
Serine/threonine-protein phosphatase |
1.906e-08 |
0.30
|
V1AR_HUMAN |
AVPR1A |
Vasopressin V1a receptor |
2.333e-08 |
0.38
|
MK08_RAT |
Mapk8 |
Mitogen-activated protein kinase 8 |
5.431e-08 |
0.28
|
GRM5_HUMAN |
GRM5 |
Metabotropic glutamate receptor 5 |
6.234e-08 |
0.37
|
VMAT2_HUMAN |
SLC18A2 |
Synaptic vesicular amine transporter |
6.816e-08 |
0.29
|
TRPV1_HUMAN |
TRPV1 |
Transient receptor potential cation channel subfamily V member 1 |
1.43e-07 |
0.37
|
ACM4_RAT |
Chrm4 |
Muscarinic acetylcholine receptor M4 |
1.593e-07 |
0.33
|
PPIA_RAT |
Ppia |
Peptidyl-prolyl cis-trans isomerase A |
1.621e-07 |
0.32
|
HYEP_HUMAN |
EPHX1 |
Epoxide hydrolase 1 |
1.812e-07 |
0.30
|
ACM1_DROME |
mAChR-A |
Muscarinic acetylcholine receptor DM1 |
2.645e-07 |
0.28
|
NLRP3_HUMAN |
NLRP3 |
NACHT, LRR and PYD domains-containing protein 3 |
3.666e-07 |
0.30
|
SC6A3_MACFA |
SLC6A3 |
Sodium-dependent dopamine transporter |
4.396e-07 |
0.29
|
SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
5.286e-07 |
0.43
|
PANC_MYCTU |
panC |
Pantothenate synthetase |
1.111e-06 |
0.34
|
ACM2_MOUSE |
Chrm2 |
Muscarinic acetylcholine receptor M2 |
1.13e-06 |
0.31
|
ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
1.402e-06 |
0.36
|
ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
1.691e-06 |
0.36
|
ACHP_LYMST |
|
Acetylcholine-binding protein |
1.984e-06 |
0.34
|
MK03_MOUSE |
Mapk3 |
Mitogen-activated protein kinase 3 |
3.175e-06 |
0.29
|
ELNE_HUMAN |
ELANE |
Neutrophil elastase |
4.685e-06 |
0.35
|
CCNA2_HUMAN |
CCNA2 |
Cyclin-A2 |
6.256e-06 |
0.32
|
CNR1_MOUSE |
Cnr1 |
Cannabinoid receptor 1 |
6.504e-06 |
0.34
|
5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
8.741e-06 |
0.52
|
MK01_MOUSE |
Mapk1 |
Mitogen-activated protein kinase 1 |
9.419e-06 |
0.31
|